Organization for the Study of Sex Differences 2025 Meeting
Dr. Heng will be an invited speaker for the "Sex and gender differences in cancer" symposium to be held at the OSSD Meeting in June 2025.
Search
Search results
13 results found
AACR 2025
A study co-led by Dr. Heng, "Circulating Epstein-Barr virus microRNAs associated with Hodgkin lymphoma prognosis" has been selected for Poster presentation at AACR 2025.
Associations of oral contraceptives with expression of CD44, CD24, and ALDH1A1 stem cell markers in women with benign breast biopsies
Yaghjyan, Lusine, Yujing J. Heng, Brian R Sardella, Maisey Ratcliffe, Bernard A Rosner, and Rulla M Tamimi. Submitted. “Associations of Oral Contraceptives With Expression of CD44, CD24, and ALDH1A1 Stem Cell Markers in Women With Benign Breast Biopsies”. Submitted, Submitted.
Simultaneous Inhibition of PARP/AKT to Intercept Nascent BRCA1/2mut Breast Tumors
Wang, Lin, Brian R Sardella, Emily K Aronson, Zhaoji Liu, Xiaohui Li, Gerburg M Wulf, and Yujing J Heng. Submitted. “Simultaneous Inhibition of PARP/AKT to Intercept Nascent BRCA1/2mut Breast Tumors”. Submitted, Submitted.
The Festival of Genomics & BioData, Boston
Dr. Heng has been invited to join the roundtable panel discussion, "Driving Innovation in Precision Medicine for Broader Implementation" at the Festival of Genomics & BioData in Boston.
SGM Cancer CARE Workshop
Dr. Heng has been selected to participate in the 2025 SGM Cancer Curriculum Advances Research Excellence (CARE) Workshop in Denver, CO. She will also present relevant basic cancer research that she is leading at the workshop.
HiRM Seminar Series 2025
Dr. Heng will be presenting, "Plasma miRNAs associated with cisplatin sensitivity in breast cancer." at the 2025 Harvard Institute for RNA Medicine (HiRM) seminar series on Tuesday, February 18th at 3 pm.
AI Student Research Symposium 2025
Dr. Heng will be a keynote speaker at AI Club's annual Research Symposium. https://corp.aiclub.world/2025-student-research-symposium
MGH Harvard Center for Reproductive Medicine 4th Symposium
Dr. Heng's abstract, "Male Immune Modulation Reduces the Efficacy of PARP Inhibition in the Treatment of Brca1 mut Breast Tumors" has been accepted for an oral presentation at the upcoming 4th Annual Reproductive Medicine Symposium. Congratulations!
Reliability of breast stromal markers immunofluorescent staining: pathologist assessment compared to quantitative image analysis
Yaghjyan, Lusine, Yujing J. Heng, Yaileen D Guzman-Arocho, Graham Colditz, Brian R Sardella, Ann Fu, K Patel, Bernard A Rosner, Maisey Ratcliff, and Rulla M Tamimi. Submitted. “Reliability of Breast Stromal Markers Immunofluorescent Staining: Pathologist Assessment Compared to Quantitative Image Analysis”. Submitted, Submitted.